Skip to content

To study the effect of the medicated drug powder made from karavira in 1st and 2nd Degree Internal Haemorrhoids.

A single arm clinical study to evaluate the efficacy of Karavira Pratisaraniya Kshara in the management of Abhyantar Arsha (1 and 2 degree Hemorhrhoids). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069919
Enrollment
32
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

None listed

Sponsors

Shrinivas Ramrao Ballore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having arsha who are fulfilling study criteria 4 out of 6 that are gud kandu vibandha size of arsha number of arsha strava raktastrava vedana Patients of age group 19 to 80 years Patients will be selected irrespective of gender

Exclusion criteria

Exclusion criteria: Patient planning to conceive in near future Pregnant and lactating mother Any congenital disease like haemophilia any major psychitric illness Patient with 3 degree 4 degree or prolapsed pile Arsha associated with ca rectum thrombosed and strangulated piles rectal prolapse fistula in ano fissure in ano HIV and HbsAG positive

Design outcomes

Primary

MeasureTime frame
To observe the efficacy of karavira pratisarniya kshara in 1 and 2 degree haemorrhoid ( arsha) Timepoint: Karavira pratisarniya kshara will applied locally on 1 and 2 degree haemorrhoids for 1 time assessment will be done before and after the treatment

Secondary

MeasureTime frame
TO OBSERVE THE ADVERSE EFFECT OF THE KARAVIRA PRATISARNIYA KSHARA.Timepoint: AFTER COMPLETION OF THE TREATMENT

Countries

India

Contacts

Public ContactDr Sanjay C Babar

Dr D Y Patil College of Ayurved and Research Centre Pimpri Pune

sanjaybabar14@gmail.com9011035602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026